3649 results for «768»
3649 results
Where to leave less behind: non-invasive CT and angiography-derived physiology for DCB lesion selection
20 May 2026 – From EuroPCR 2026
This session elucidates the role of non-invasive coronary CT and angiography-derived physiology in guiding lesion selection for drug-eluting balloon PCI. It emphasises integrating anatomical and physiological data to refine lesion preparation, strategy, and validation beyond angiography, and identifies scenarios where DEB PCI may not be optimal,...
New evidence in the treatment of calcified lesions
19 May 2026 – From EuroPCR 2026
This session presents the latest evidence on treating calcified coronary lesions, comparing intravascular lithotripsy, cutting balloons, rotational and orbital atherectomy. It includes clinical trial data on efficacy, safety, and impact on coronary microvascular function, providing a robust foundation for evidence-based decision-making in calcified lesion management.
Reshaping what's possible in complex PCI with advanced sirolimus technology
21 May 2026 – From EuroPCR 2026
Focused on advancing complex PCI, this session explores strategies to minimise metal use through advanced sirolimus technologies and drug-coated balloon (DCB) therapies. It highlights the biological and pharmacokinetic characteristics of DCBs, key device design considerations, and practical approaches to less-metal PCI. Clinical cases illustrate challenges such...
TAVI procedural complications - Part 1: VSD, valve embolisation, and more
19 May 2026 – From EuroPCR 2026
This session focuses on the complex complications that can arise during TAVI procedures, such as ventricular septal defects, valve embolisation, and other critical events. Through detailed case analyses, it offers strategies for recognition, prevention, and management to improve patient safety and outcomes.
Innovations in vascular therapies
19 May 2026 – From EuroPCR 2026
Discover cutting-edge innovations in vascular therapies highlighting novel technologies such as Pulse Intravascular Lithotripsy (IVL) for calcium modification and Amplitude Vascular Systems. The session also presents drug-free restenosis control strategies via CD31 camouflage coating promoting physiological-grade healing, emphasizing emerging solutions aimed at improving vascular intervention outcomes.
RESIL-Card in action: early European experience and lessons from the first users
19 May 2026 – From EuroPCR 2026
This session presents the early European experience with the RESIL-Card tool, designed to optimize interventional cardiology care pathways during crises. It includes practical insights from early adopters, updates on dissemination efforts across Europe, strategies for engaging patients and organizations, and discussions on national and EU political...
Aortic paravalvular leak unmasked: different faces, different strategies
19 May 2026 – From EuroPCR 2026
Examine diverse clinical scenarios and management strategies for aortic paravalvular leaks (PVL), including complex percutaneous closures post-TAVI and surgical interventions. This session presents challenging cases demonstrating varied presentations and approaches such as mechanical valve loop utilization, highlighting the complexities and tailored solutions required for successful PVL...
What bench testing teaches us about real world PCI
19 May 2026 – From EuroPCR 2026
This session explores bench testing insights into real-world percutaneous coronary interventions (PCI). Topics include comparative expansion ratios of coronary stents, prognostic assessments after drug-coated balloon treatments, mechanical performance of magnesium scaffolds in bifurcations, preclinical safety and computational modeling of bioresorbable polymer-coated stents, and evaluations of commonly...
Imaging-driven decision making in PCI for calcified lesions
19 May 2026 – From EuroPCR 2026
Focus on imaging-guided decision making in PCI for heavily calcified coronary lesions. This session includes case studies illustrating advanced techniques to navigate and treat challenging calcific anatomies, emphasizing the role of imaging modalities and atherectomy devices to optimize procedural success in complex settings such as left...
Complication management in CTO PCI - Part 1
19 May 2026 – From EuroPCR 2026
This session addresses complication management during chronic total occlusion (CTO) percutaneous coronary interventions. It covers strategies for unexpected coronary complications, managing tamponade without visible perforation, rescue techniques for atherectomy-related perforations, managing dry pericardial tamponade after septal branch perforation, and challenges when retrograde approaches encounter thrombosis in...
TAVI procedural complications - Part 2: devices issues, access-related complications and more
19 May 2026 – From EuroPCR 2026
Delve into procedural challenges encountered during TAVI, focusing on device-related issues, access complications, and bailout strategies. This session reviews real-world cases such as balloon retention, valve expansion failure, TAV-in-TAV interventions, and transcaval access lessons, providing critical insights to manage and mitigate procedural complications effectively.
CTO PCI: technical developments
19 May 2026 – From EuroPCR 2026
This session highlights technical developments in CTO PCI, featuring comparative insights from the ONUBA-CTO study on retrograde versus antegrade approaches, sex-based differences in long-term outcomes, management of balloon-undilatable lesions, the role of virtual reality audiovisual distraction, the impact of core laboratory feedback with OCT, and contemporary...
Complex PCI in patients with acute coronary syndrome
19 May 2026 – From EuroPCR 2026
Explore complex PCI management in acute coronary syndrome patients through detailed case presentations illustrating complication handling and bailout techniques. Learn from challenging scenarios including graft perforation, no-flow situations, guidewire dissections, and stent dislodgement, emphasizing preparedness and strategic responses to improve clinical outcomes in high-risk interventions.
Behind standard practice: a place for DCB
19 May 2026 – From EuroPCR 2026
This session examines the role of drug-coated balloons (DCB) beyond standard practice in coronary revascularization. It includes discussions on revascularization strategies in young patients, rescue of early distal LIMA–LAD anastomosis, treatment of in-stent restenosis, stepwise complex CTO bifurcation revascularization using kissing DCBs, and management of calcified...
Best complications in primary PCI
19 May 2026 – From EuroPCR 2026
This session delves into a spectrum of challenging complications encountered during primary PCI, showcasing advanced management techniques and unique case scenarios. Highlights include managing complex cathlab nightmares, innovative IVUS-guided true lumen re-entry strategies, and critical decision-making in coronary artery dissections.
TAVI today and tomorrow: international trends and future direction
14 Feb 2026 – From PCR Tokyo Valves 2026
This session focuses on the evolving landscape of TAVI, emphasising lifetime management strategies with a focus on the first valve implanted. It provides a comprehensive discussion on representative patient profiles, current guidelines from various countries, and future outlooks, alongside recent long-term clinical results for the balloon-expandable...
Built to last: lifetime management for durability and beyond
14 Feb 2026 – From PCR Tokyo Valves 2026
This session addresses the principles of lifetime management aimed at durability and optimal long-term outcomes in complex valvular heart disease cases. Key topics include the critical importance of initial valve choice, practical tips for optimizing paravalvular leak (PVL) management, and advanced strategies for redo transcatheter aortic...
Protect the brain for TAVI - True potential of SENTINEL Cerebral Protection System
14 Feb 2026 – From PCR Tokyo Valves 2026
This session highlights the critical role of cerebral protection during TAVI procedures by focusing on the SENTINEL Cerebral Protection System. It reviews trends in the United States and Japan, presents clinical outcomes one year post-introduction in Japan, and examines key clinical trials through a meta-analysis comparing...
Patient selection for tricuspid TEER in 2026
14 Feb 2026 – From PCR Tokyo Valves 2026
This session focuses on optimizing patient selection for tricuspid transcatheter edge-to-edge repair (TEER) in 2026. It integrates anatomical, haemodynamic, and clinical criteria to identify ideal candidates, explores evolving treatment boundaries between TEER, transcatheter tricuspid valve replacement (TTVR), and medical management, and applies evidence from key trials...
Procedural optimisation for enhanced acute and long-term outcomes
14 Feb 2026 – From PCR Tokyo Valves 2026
This session emphasizes procedural optimization in TAVI to enhance both acute and long-term outcomes. It highlights critical factors such as valve sizing, expansion, implantation depth, and commissural alignment. Practical techniques for pre- and post-dilatation alongside commissural alignment are demonstrated through real cath lab cases, underscoring their...
